contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


stenocare-as-notice-for-deadline-of-trading-to2-warrants

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Stenocare

STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENOStenocare TO2 Warrant trading will end close of business June 19. To benefit from the discounted share price of DKK 3.16 ...

<div class="abstract">STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENOStenocare TO2 Warrant trading will end close of business June 19. To benefit from the discounted share price of DKK 3.16 each, subscribers need to own TO2 Warrants (ticker: STENO TO2).</div>Stenocare is currently offering a time-limited share issue for owners of TO2 Warrants. These warrants can be purchased and/or sold until the deadline of June 19, 2024, at 17:00 Central European Summer Time.The TO2 Warrants can be used to subscribe to (purchase) the new Stenocare shares at a discounted price of DKK 3.16 each during the exercise period from June 10 to June 21. TO2 Warrant owners who decide to subscribe before this deadline must instruct their bank to exercise (use) the TO2 Warrants.Please note that TO2 Warrants not exercised (used) before June 21 will be void and cannot be traded after the deadline.The investment brochureTo inform existing shareholders of Stenocare and other investors and stakeholders about the exercise of TO2 warrants, an investment brochure has been prepared. This brochure contains details about the Company, its business, products and strategy. Information is also available on the investor website of Stenocare https://stenocare.com/share-issue-to2-2024/<ul><li>Link to English brochure: <a href="https://stenocare.com/wp-content/uploads/2024/06/STENOCARE-TO2-Warrant-exercise-ENG.pdf">https://stenocare.com/wp-content/uploads/2024/06/STENOCARE-TO2-Warrant-exercise-ENG.pdf</a></li><li>Link to Danish brochure: <a href="https://stenocare.com/wp-content/uploads/2024/06/STENOCARE-TO2-Warrant-udnyttelse-DK_.pdf">https://stenocare.com/wp-content/uploads/2024/06/STENOCARE-TO2-Warrant-udnyttelse-DK_.pdf</a></li><li>Link to Swedish brochure: <a href="https://stenocare.com/wp-content/uploads/2024/06/STENOCARE-TO2-Warrant-nyttjande-SE_.pdf">https://stenocare.com/wp-content/uploads/2024/06/STENOCARE-TO2-Warrant-nyttjande-SE_.pdf</a></li></ul>On the Stenocare Facebook wall, there are also two 15 minutes interviews with Proinvestor.com and STOKK.IO - that provide more information about the TO2 Warrant and the company: <a href="https://www.facebook.com/stenocare">https://www.facebook.com/stenocare</a>The summarySummarized terms for the warrants of series TO2:<ul><li>Exercise price: 3.16 DKK per share - ticker: [STENO TO 2] / ISIN DK0062493615</li><li>Exercise period: 10 June 2024 - 21 June 2024 (both days included)</li><li>Last day of trading warrants of series TO2: 19 June 2024</li><li>Issue volume: 1,712,999 warrants of series TO2</li><li>Dilution: Up to 8.5 percent</li></ul>

Stay up to date with our newsletter